Article by Sue McGreevey and Mike Morrison courtesy of the Harvard Gazette
A new global collaborative study has confirmed that vitamin D supplementation can help protect against acute respiratory infections. The study, a participant data meta-analysis of 25 randomized controlled trials including more than 11,000 participants, has been published online in The BMJ.
“Most people understand that vitamin D is critical for bone and muscle health,” said Carlos Camargo of the Department of Emergency Medicine at Massachusetts General Hospital (MGH), the study’s senior author. “Our analysis has also found that it helps the body fight acute respiratory infection, which is responsible for millions of deaths globally each year.”
Several observational studies, which track participants over time without assigning a specific treatment, have associated low vitamin D levels with greater susceptibility to acute respiratory infections. A number of clinical trials have been conducted to investigate the protective ability of vitamin D supplementation, but while some found a protective effect, others did not. Meta-analyses of these trials, which aggregate data from several studies that may have different designs or participant qualifications, also had conflicting results.
To resolve these discrepancies, the research team — led by Adrian Martineau from Queen Mary University of London — conducted an individual participant data meta-analysis of trials in more than a dozen countries, including the U.S., Canada, and the U.K. While traditional meta-analyses compare average data from all participants in each study, individual participant data meta-analysis separates out the data from each individual participant, producing what could be considered a higher-resolution analysis of the data from all studies.
The investigators found that daily or weekly supplementation had the greatest benefit for individuals with the most significant vitamin D deficiency (blood levels below 10 mg/dl) — cutting their risk of respiratory infection in half — and that all participants experienced some beneficial effects from regular vitamin D supplementation. Administering occasional high doses of vitamin D did not produce significant benefits.
“Acute respiratory infections are responsible for millions of emergency department visits in the United States,” said Camargo, who is a professor of emergency medicine at Harvard Medical School. “These results could have a major impact on our health system and also support efforts to fortify foods with vitamin D, especially in populations with high levels of vitamin D deficiency.”
The study was funded by a grant from the National Institute of Health Research (U.K.).
THE INFORMATION ABOVE IS FOR INFORMATION PURPOSES ONLY. IT IS THE RESPONSIBILITY OF EACH INDIVIDUAL TO MANAGE THEIR OWN HEALTH AND WELLBEING AND THEY ALONE ARE SOLELY RESPONSIBLE FOR ALL DECISIONS MADE IN THIS RESPECT. THE INFORMATION ABOVE COULD BE CONSIDERED BY AN INDIVIDUALS MEDICAL PROFESSIONAL WHEN INVESTIGATING PREVENTION MEASURES AND TREATMENT FOR CORONAVIRUS. THE ABOVE SHOULD NOT BE CONSIDERED TO BE ADVICE TO FOLLOW WITHOUT FIRST CONSULTING YOUR MEDICAL PROFESSIONAL WHO IS ABLE TO ADVISE ON THE SUITABILITY, RISK AND BENEFITS WITH RESPECT TO EACH INDIVIDUAL AFTER TAKING ACCOUNT OF EACH PERSONS PARTICULAR CIRCUMSTANCES, MEDICAL HISTORY, PRE-EXISTING CONDITIONS, ALLERGIES AND OTHER RELEVANT MEDICAL FACTORS.
DO NOT USE THE ABOVE INFORMATION TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE, SICKNESS OR AILMENT, FOR THERAPEUTIC PURPOSES OR AS A SUBSTITUTE FOR THE ADVICE OF A HEALTH PROFESSIONAL. INDIVIDUALS USING THE ABOVE INFORMATION DO SO AT THEIR SOLE RISK AND THEY TOGETHER WITH THEIR FAMILY, AGENTS, EXECUTORS AND ASSIGNS FULLY RELEASE AND HOLD HARMLESS MRS GINA RINEHART, HANCOCK PROSPECTING PTY LTD, ITS DIRECTORS, OFFICERS, SUBSIDIARIES AND RELATED ENTITIES FROM ANY CLAIMS, DAMAGES, DISTRESS OR OTHERWISE THAT MAY BE SUFFERED, ARISE OR BE CAUSED IN ANY WAY WHATSOEVER FROM FOLLOWING, RELYING ON, OR IN ANY WAY WHATSOEVER READING OR USING THE INFORMATION ABOVE.
MRS GINA RINEHART, HANCOCK PROSPECTING PTY LTD, ITS DIRECTORS, OFFICERS, ITS SUBSIDIARIES AND RELATED ENTITIES TAKE NO RESPONSIBILITY FOR THE VERACITY OF THE INFORMATION SHOWN ABOVE AND TO THE FULLEST EXTENT POSSIBLE DISCLAIM ALL AND ANY LIABILITY FOR ANY DIRECT, INDIRECT, SPECIAL, EXEMPLARY OR OTHER DAMAGES OR NEGATIVE HEALTH EFFECTS THAT MAY ARISE FROM UTILISING ANY OF THE ABOVE INFORMATION SHOULD ANY MEDICAL PROFESSIONAL OR INDIVIDUAL CHOOSE TO FOLLOW ANY PART OF THE ABOVE INFORMATION. PLEASE DO NOT READ FURTHER UNLESS YOU AGREE THAT YOU WILL NOT AT ANY TIME SEEK TO HOLD MRS GINA RINEHART, HANCOCK PROSPECTING PTY LTD, ITS DIRECTORS, OR OFFICERS OR ANY OF ITS SUBSIDIARIES OR ITS RELATED ENTITIES RESPONSIBLE IN ANY WAY.